Evaluation of radiation maculopathy after treatment of choroidal melanoma with ruthenium-106 using optical coherence tomography angiography

Abstract Background To assess the impact of brachytherapy on macular microvasculature utilizing optical coherence tomography angiography (OCTA) in treated choroidal melanoma. Methods In this retrospective observational case series, we reviewed the recorded data of the patients with unilateral extram...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Ali Torkashvand, Hamid Riazi-Esfahani, Fariba Ghassemi, Elias Khalili Pour, Babak Masoomian, Mohammad Zarei, Kaveh Fadakar, Mojtaba Arjmand, Fereshteh Tayebi, Leila Ekradi, Hamid Abrishami Moghaddam, Tahereh Mahmoudi, Reihaneh Daneshmand, Hooshang Faghihi
Formato: article
Lenguaje:EN
Publicado: BMC 2021
Materias:
Acceso en línea:https://doaj.org/article/83c7accdf7bb4de8a281d42ff98ed5bc
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:83c7accdf7bb4de8a281d42ff98ed5bc
record_format dspace
spelling oai:doaj.org-article:83c7accdf7bb4de8a281d42ff98ed5bc2021-11-08T11:19:28ZEvaluation of radiation maculopathy after treatment of choroidal melanoma with ruthenium-106 using optical coherence tomography angiography10.1186/s12886-021-02140-w1471-2415https://doaj.org/article/83c7accdf7bb4de8a281d42ff98ed5bc2021-11-01T00:00:00Zhttps://doi.org/10.1186/s12886-021-02140-whttps://doaj.org/toc/1471-2415Abstract Background To assess the impact of brachytherapy on macular microvasculature utilizing optical coherence tomography angiography (OCTA) in treated choroidal melanoma. Methods In this retrospective observational case series, we reviewed the recorded data of the patients with unilateral extramacular choroidal melanoma treated with ruthenium − 106 (106Ru) plaque radiotherapy with a follow-up period of more than 6 months. Automatically measured OCTA retinal parameters were analysed after image processing. Results Thirty-one eyes of 31 patients with the mean age of 51.1 years were recruited. Six eyes had no radiation maculopathy (RM). From 25 eyes with RM, nine eyes (36%) revealed a burnout macular microvasculature with imperceptible vascular details. Twenty-one non-irradiated fellow eyes from the enrolled patients were considered as the control group. Foveal and optic disc radiation dose had the highest value to predict the burnout pattern (ROC, AUC: 0.763, 0.727). Superficial and deep foveal avascular zone (FAZ) were larger in irradiated eyes in comparison to non-irradiated fellow eyes (1629 μm2 vs. 428 μm2, P = 0.005; 1837 μm2 vs 268 μm2, P = 0.021; respectively). Foveal and parafoveal vascular area density (VAD) and vascular skeleton density (VSD) in both superficial and deep capillary plexus (SCP and DCP) were decreased in all irradiated eyes in comparison with non-irradiated fellow eyes (P < 0.001). Compared with non-irradiated fellow eyes, irradiated eyes without RM had significantly lower VAD and VSD at foveal and parafoveal DCP (all P < 0.02). However, these differences at SCP were not statistically significant. Conclusion The OCTA is a valuable tool for evaluating RM. Initial subclinical microvascular insult after 106Ru brachytherapy is more likely to occur in DCP. The deep FAZ area was identified as a more critical biomarker of BCVA than superficial FAZ in these patients.Ali TorkashvandHamid Riazi-EsfahaniFariba GhassemiElias Khalili PourBabak MasoomianMohammad ZareiKaveh FadakarMojtaba ArjmandFereshteh TayebiLeila EkradiHamid Abrishami MoghaddamTahereh MahmoudiReihaneh DaneshmandHooshang FaghihiBMCarticleDeep capillary plexusFoveal avascular zone (FAZ)Radiation maculopathyRadiation retinopathyRetina burnoutRuthenium-106OphthalmologyRE1-994ENBMC Ophthalmology, Vol 21, Iss 1, Pp 1-11 (2021)
institution DOAJ
collection DOAJ
language EN
topic Deep capillary plexus
Foveal avascular zone (FAZ)
Radiation maculopathy
Radiation retinopathy
Retina burnout
Ruthenium-106
Ophthalmology
RE1-994
spellingShingle Deep capillary plexus
Foveal avascular zone (FAZ)
Radiation maculopathy
Radiation retinopathy
Retina burnout
Ruthenium-106
Ophthalmology
RE1-994
Ali Torkashvand
Hamid Riazi-Esfahani
Fariba Ghassemi
Elias Khalili Pour
Babak Masoomian
Mohammad Zarei
Kaveh Fadakar
Mojtaba Arjmand
Fereshteh Tayebi
Leila Ekradi
Hamid Abrishami Moghaddam
Tahereh Mahmoudi
Reihaneh Daneshmand
Hooshang Faghihi
Evaluation of radiation maculopathy after treatment of choroidal melanoma with ruthenium-106 using optical coherence tomography angiography
description Abstract Background To assess the impact of brachytherapy on macular microvasculature utilizing optical coherence tomography angiography (OCTA) in treated choroidal melanoma. Methods In this retrospective observational case series, we reviewed the recorded data of the patients with unilateral extramacular choroidal melanoma treated with ruthenium − 106 (106Ru) plaque radiotherapy with a follow-up period of more than 6 months. Automatically measured OCTA retinal parameters were analysed after image processing. Results Thirty-one eyes of 31 patients with the mean age of 51.1 years were recruited. Six eyes had no radiation maculopathy (RM). From 25 eyes with RM, nine eyes (36%) revealed a burnout macular microvasculature with imperceptible vascular details. Twenty-one non-irradiated fellow eyes from the enrolled patients were considered as the control group. Foveal and optic disc radiation dose had the highest value to predict the burnout pattern (ROC, AUC: 0.763, 0.727). Superficial and deep foveal avascular zone (FAZ) were larger in irradiated eyes in comparison to non-irradiated fellow eyes (1629 μm2 vs. 428 μm2, P = 0.005; 1837 μm2 vs 268 μm2, P = 0.021; respectively). Foveal and parafoveal vascular area density (VAD) and vascular skeleton density (VSD) in both superficial and deep capillary plexus (SCP and DCP) were decreased in all irradiated eyes in comparison with non-irradiated fellow eyes (P < 0.001). Compared with non-irradiated fellow eyes, irradiated eyes without RM had significantly lower VAD and VSD at foveal and parafoveal DCP (all P < 0.02). However, these differences at SCP were not statistically significant. Conclusion The OCTA is a valuable tool for evaluating RM. Initial subclinical microvascular insult after 106Ru brachytherapy is more likely to occur in DCP. The deep FAZ area was identified as a more critical biomarker of BCVA than superficial FAZ in these patients.
format article
author Ali Torkashvand
Hamid Riazi-Esfahani
Fariba Ghassemi
Elias Khalili Pour
Babak Masoomian
Mohammad Zarei
Kaveh Fadakar
Mojtaba Arjmand
Fereshteh Tayebi
Leila Ekradi
Hamid Abrishami Moghaddam
Tahereh Mahmoudi
Reihaneh Daneshmand
Hooshang Faghihi
author_facet Ali Torkashvand
Hamid Riazi-Esfahani
Fariba Ghassemi
Elias Khalili Pour
Babak Masoomian
Mohammad Zarei
Kaveh Fadakar
Mojtaba Arjmand
Fereshteh Tayebi
Leila Ekradi
Hamid Abrishami Moghaddam
Tahereh Mahmoudi
Reihaneh Daneshmand
Hooshang Faghihi
author_sort Ali Torkashvand
title Evaluation of radiation maculopathy after treatment of choroidal melanoma with ruthenium-106 using optical coherence tomography angiography
title_short Evaluation of radiation maculopathy after treatment of choroidal melanoma with ruthenium-106 using optical coherence tomography angiography
title_full Evaluation of radiation maculopathy after treatment of choroidal melanoma with ruthenium-106 using optical coherence tomography angiography
title_fullStr Evaluation of radiation maculopathy after treatment of choroidal melanoma with ruthenium-106 using optical coherence tomography angiography
title_full_unstemmed Evaluation of radiation maculopathy after treatment of choroidal melanoma with ruthenium-106 using optical coherence tomography angiography
title_sort evaluation of radiation maculopathy after treatment of choroidal melanoma with ruthenium-106 using optical coherence tomography angiography
publisher BMC
publishDate 2021
url https://doaj.org/article/83c7accdf7bb4de8a281d42ff98ed5bc
work_keys_str_mv AT alitorkashvand evaluationofradiationmaculopathyaftertreatmentofchoroidalmelanomawithruthenium106usingopticalcoherencetomographyangiography
AT hamidriaziesfahani evaluationofradiationmaculopathyaftertreatmentofchoroidalmelanomawithruthenium106usingopticalcoherencetomographyangiography
AT faribaghassemi evaluationofradiationmaculopathyaftertreatmentofchoroidalmelanomawithruthenium106usingopticalcoherencetomographyangiography
AT eliaskhalilipour evaluationofradiationmaculopathyaftertreatmentofchoroidalmelanomawithruthenium106usingopticalcoherencetomographyangiography
AT babakmasoomian evaluationofradiationmaculopathyaftertreatmentofchoroidalmelanomawithruthenium106usingopticalcoherencetomographyangiography
AT mohammadzarei evaluationofradiationmaculopathyaftertreatmentofchoroidalmelanomawithruthenium106usingopticalcoherencetomographyangiography
AT kavehfadakar evaluationofradiationmaculopathyaftertreatmentofchoroidalmelanomawithruthenium106usingopticalcoherencetomographyangiography
AT mojtabaarjmand evaluationofradiationmaculopathyaftertreatmentofchoroidalmelanomawithruthenium106usingopticalcoherencetomographyangiography
AT fereshtehtayebi evaluationofradiationmaculopathyaftertreatmentofchoroidalmelanomawithruthenium106usingopticalcoherencetomographyangiography
AT leilaekradi evaluationofradiationmaculopathyaftertreatmentofchoroidalmelanomawithruthenium106usingopticalcoherencetomographyangiography
AT hamidabrishamimoghaddam evaluationofradiationmaculopathyaftertreatmentofchoroidalmelanomawithruthenium106usingopticalcoherencetomographyangiography
AT taherehmahmoudi evaluationofradiationmaculopathyaftertreatmentofchoroidalmelanomawithruthenium106usingopticalcoherencetomographyangiography
AT reihanehdaneshmand evaluationofradiationmaculopathyaftertreatmentofchoroidalmelanomawithruthenium106usingopticalcoherencetomographyangiography
AT hooshangfaghihi evaluationofradiationmaculopathyaftertreatmentofchoroidalmelanomawithruthenium106usingopticalcoherencetomographyangiography
_version_ 1718442257072259072